0001567619-18-007116.txt : 20181129 0001567619-18-007116.hdr.sgml : 20181129 20181129164125 ACCESSION NUMBER: 0001567619-18-007116 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181127 FILED AS OF DATE: 20181129 DATE AS OF CHANGE: 20181129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bailey Sue CENTRAL INDEX KEY: 0001403769 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 181208897 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DRIVE STREET 2: SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 BUSINESS PHONE: 240-631-3200 MAIL ADDRESS: STREET 1: 400 PROFESSIONAL DR, SUITE 400 CITY: GAITHERSBURG STATE: MD ZIP: 20879 4 1 doc1.xml FORM 4 X0306 4 2018-11-27 0 0001367644 Emergent BioSolutions Inc. EBS 0001403769 Bailey Sue 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 1 0 0 0 Common Stock 2018-11-27 4 M 0 8244 18.64 A 57216 D Common Stock 2018-11-27 4 S 0 8244 69.6197 D 48972 D Common Stock 2018-11-27 4 M 0 1579 20.08 A 50551 D Common Stock 2018-11-27 4 S 0 1579 69.6197 D 48972 D Common Stock 2018-11-27 4 M 0 4736 13.00 A 53708 D Common Stock 2018-11-27 4 S 0 4736 69.6197 D 48972 D Common Stock 2018-11-27 4 M 0 3158 13.37 A 52130 D Common Stock 2018-11-27 4 S 0 3158 69.6197 D 48972 D Stock Option (Right to buy) 18.64 2018-11-27 4 M 0 8244 0 D 2021-05-21 Common Stock 8244 0 D Stock Option (Right to buy) 20.08 2018-11-27 4 M 0 1579 0 D 2021-05-18 Common Stock 1579 0 D Stock Option (Right to buy) 13.00 2018-11-27 4 M 0 4736 0 D 2020-05-22 Common Stock 4736 0 D Stock Option (Right to buy) 13.37 2018-11-27 4 M 0 3158 0 D 2019-05-16 Common Stock 3158 0 D The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $69.50 to $70.05, inclusive. Consists of an option granted under the company's stock incentive plan as amended and restated. The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant. /s/ S. Scott Lieberman, Attorney-in-fact 2018-11-29